Current pharmacotherapeutic options for primary dyslipidemia in adults

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of mortality and disability.
• Dyslipidemia is a major modifiable risk factor for ASCVD.
• Current guidelines emphasize lipid control strategies for a significant portion of the population.

Purpose of the Study:

• To review therapeutic options for managing lipid disorders in adults.
• To highlight the role of statins as first-line therapy.
• To address challenges in patient adherence and persistence with lipid-lowering treatments.

Main Methods:

• Literature review of evidence-based guidelines and studies on lipid management.
• Analysis of current therapeutic strategies for hypercholesterolemia.
• Discussion of factors influencing patient adherence and treatment persistence.

Main Results:

• Statins are the established first-line treatment for hypercholesterolemia, with varying potency across medications.
• Optimizing statin dosage and selection is essential for achieving lipid targets.
• Patient adherence and persistence are critical challenges in long-term lipid management.

Conclusions:

• Effective lipid management requires appropriate drug selection, adequate dosing, and consideration of drug interactions and side effects.
• Tailoring treatment strategies to individual patients is key to improving adherence and achieving therapeutic goals.
• Addressing adherence barriers is paramount for successful long-term management of dyslipidemia and prevention of ASCVD.